Mesenchymal stem cells in osteoarticular pediatric diseases: an update
Authors:
- Maroun KhouryMKMaroun Khoury
- Christian JorgensenCJChristian Jorgensen
- 15 February 2012
- journal article
- review article
- Published by Springer Nature in Pediatric Research
- Vol. 71 (2-4) , 452-458
Abstract
Cellular therapy has gained an increasing popularity in recent years. Mesenchymal stem cells (MSCs) have the potential to differentiate into bone, cartilage, or fat tissue. In recent studies, these cells have also shown healing capability by improving angiogenesis and preventing fibrosis, which could have a role in tissue repair and tissue regeneration. Preclinical and clinical orthopedic studies conducted in the adult population support the use of MSCs for bone-healing problems, early stages of osteonecrosis, and local bone defects. Only a few published studies support the use of MSCs in pediatric osteoarticular disorders, probably due to the unknown long-term results of cellular therapy. The purpose of this review is to explain the mechanism by which MSCs could exhibit a therapeutic role in pediatric osteoarticular disorders.Keywords
This publication has 56 references indexed in Scilit:
- Stem cell therapy for articular cartilage defectsBritish Medical Bulletin, 2011
- Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patientsInternational Journal of Rheumatic Diseases, 2011
- Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 monthsJournal of Tissue Engineering and Regenerative Medicine, 2011
- Effects of Multiple Drilling on the Ischemic Capital Femoral Epiphysis of Immature PigletsYonsei Medical Journal, 2011
- IL-6-Dependent PGE2 Secretion by Mesenchymal Stem Cells Inhibits Local Inflammation in Experimental ArthritisPLOS ONE, 2010
- Injection of Demineralized Bone Matrix With Bone Marrow Concentrate Improves Healing in Unicameral Bone CystClinical Orthopaedics and Related Research, 2010
- Discrepancy between the in vitro and in vivoeffects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritisArthritis Research & Therapy, 2010
- Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2010
- Osteogenesis imperfecta: questions and answersCurrent Opinion in Pediatrics, 2009
- Donor cell–derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantationBlood, 2008